![Madhu Cherukury](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Madhu Cherukury
Chief Executive Officer at Allgenesis Biotherapeutics, Inc.
Madhu Cherukury active positions
Companies | Position | Start | End |
---|---|---|---|
Allgenesis Biotherapeutics, Inc.
![]() Allgenesis Biotherapeutics, Inc. BiotechnologyHealth Technology Allgenesis Biotherapeutics, Inc. is a Taiwanese clinical-stage biopharmaceutical company focused on researching and developing novel medicines for the treatment of eye diseases. The private company is based in Taipei, Taiwan. The company's current pipeline includes potential blockbuster drugs such as ag-73305 for the treatment of DME, NAMD, and other retinal diseases, as well as ag-80308 for dry eye disease. The company was founded by Chih Lung Shen and Chih Ming Chen. Madhu Cherukury has been the CEO of the company since 2014. | Director/Board Member | - | - |
Chief Executive Officer | 31/05/2018 | - |
Career history of Madhu Cherukury
Statistics
International
Taiwan | 2 |
Operational
Director/Board Member | 1 |
Chief Executive Officer | 1 |
Sectoral
Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 1 |
---|---|
Allgenesis Biotherapeutics, Inc.
![]() Allgenesis Biotherapeutics, Inc. BiotechnologyHealth Technology Allgenesis Biotherapeutics, Inc. is a Taiwanese clinical-stage biopharmaceutical company focused on researching and developing novel medicines for the treatment of eye diseases. The private company is based in Taipei, Taiwan. The company's current pipeline includes potential blockbuster drugs such as ag-73305 for the treatment of DME, NAMD, and other retinal diseases, as well as ag-80308 for dry eye disease. The company was founded by Chih Lung Shen and Chih Ming Chen. Madhu Cherukury has been the CEO of the company since 2014. | Health Technology |
- Stock Market
- Insiders
- Madhu Cherukury
- Experience